WT Wealth Management Boosts Holdings in VanEck Pharmaceutical ETF $PPH

WT Wealth Management raised its position in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 19.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 50,384 shares of the company’s stock after acquiring an additional 8,252 shares during the period. VanEck Pharmaceutical ETF makes up approximately 1.6% of WT Wealth Management’s holdings, making the stock its 19th biggest holding. WT Wealth Management owned 0.51% of VanEck Pharmaceutical ETF worth $5,234,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of PPH. AlphaCore Capital LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter worth $31,000. Group One Trading LLC acquired a new position in VanEck Pharmaceutical ETF during the 4th quarter valued at about $36,000. IFP Advisors Inc raised its stake in VanEck Pharmaceutical ETF by 53.7% in the third quarter. IFP Advisors Inc now owns 438 shares of the company’s stock valued at $40,000 after buying an additional 153 shares during the last quarter. Advisory Services Network LLC purchased a new stake in VanEck Pharmaceutical ETF in the third quarter valued at about $41,000. Finally, EFG International AG acquired a new stake in VanEck Pharmaceutical ETF in the fourth quarter worth about $44,000.

VanEck Pharmaceutical ETF Stock Performance

Shares of NASDAQ PPH opened at $109.44 on Friday. VanEck Pharmaceutical ETF has a fifty-two week low of $81.74 and a fifty-two week high of $112.58. The company has a market cap of $1.04 billion, a PE ratio of 20.21 and a beta of 0.47. The business has a 50-day simple moving average of $103.24 and a two-hundred day simple moving average of $104.61.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 7th. Investors of record on Wednesday, April 1st were paid a $0.8441 dividend. This is a boost from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31. The ex-dividend date was Wednesday, April 1st. This represents a $3.38 dividend on an annualized basis and a yield of 3.1%.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.